BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, will release fourth quarter and year-end consolidated financial results before the market opens on Thursday, February 19. Following the release, the Company will host a conference call at 11:00 a.m. Eastern.